Dengue Fever
101
6
10
70
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
36 trials with published results (36%)
Research Maturity
70 completed trials (69% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
2.0%
2 terminated out of 101 trials
97.2%
+10.7% vs benchmark
16%
16 trials in Phase 3/4
51%
36 of 70 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 70 completed trials
Clinical Trials (101)
Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose
Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)
A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults
Smart Analysis and Decision-Making for Emerging Infectious Diseases
A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers
Abdominal Sonographic Findings and Their Association With Thrombocytopenia in Dengue Fever: A Cross-Sectional Study From an Endemic Region
A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia
IC14 in Adult Patients With Dengue Fever
A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)
A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue
Xpert® Tropical Fever Test on GeneXpert® Edge X System
Prediction of Infectious Diseases in LMICs Using Electronic Health Record Data
International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)
A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan
A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)
Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection
To Assess the Efficacy of Carica Papaya Leaf Extract in Improving Platelet Counts Among Pediatric Patients With Dengue-associated Thrombocytopenia
Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults
Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2)